Literature DB >> 15454329

Herd-level seroprevalence and risk-mapping of bovine hypodermosis in Belgian cattle herds.

D Haine1, F Boelaert, D U Pfeiffer, C Saegerman, J-F Lonneux, B Losson, K Mintiens.   

Abstract

Our objective was to determine the seroprevalence of Hypoderma spp. and to develop a spatial model describing the risk surface of warble-fly infection in Belgian cattle herds (adjusting for herd size, herd type, local temperature, rainfall, relative air humidity and land-cover). This survey was carried out in 390 selected herds of all types (dairy, mixed and beef) from December 1997 to March 1998, which were included in a national infectious bovine rhinotracheitis and paratuberculosis (Johne's-disease) survey. All animals >24 months old were blood sampled and an ELISA was used on pooled serum samples (10 animals per pool). The herd seroprevalence was 48.7% (95% confidence interval: 43.6-53.8); positive herds were mainly in the south of the country and along the North Sea coast. The logistic multiple-regression model of herd-level seropositivity indicated that mixed-type and beef-cattle herds have more than four-fold and two-fold increases in the odds of being Hypoderma-positive, respectively, compared with dairy herds.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15454329     DOI: 10.1016/j.prevetmed.2004.06.005

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  2 in total

1.  Integrating fasciolosis control in the dry cow management: the effect of closantel treatment on milk production.

Authors:  Johannes Charlier; Miel Hostens; Jos Jacobs; Bonny Van Ranst; Luc Duchateau; Jozef Vercruysse
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

2.  Treatment and control of bovine hypodermosis with ivermectin long-acting injection (IVOMEC® GOLD).

Authors:  Domenico Otranto; Greg Johnson; Kevin Syvrud; Stephen Yoon; James S Hunter; Steffen Rehbein
Journal:  Parasit Vectors       Date:  2016-10-18       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.